Please click on an icon to download a file. You can view and download presentations from other days of the conference by clicking on the links below:
Click here to view presentations from the BHIVA Young Consultants Forum (Tuesday 17th April 2012).
BHIVA Invited Lecture 1
Kaposi's sarcoma in the era of HAART
Professor Mark Bower, Chelsea and Westminster Hospital, London
BHIVA is grateful for an educational grant in support of this lecture from Galen Ltd.
BHIVA Debate - Interferon-sparing regimens for hepatitis C
The motion:
This house believes that we should treat hepatitis C with pegylated interferon and direct-acting antivirals rather than wait for interferon-free options.
For the motion:
Dr Mark Nelson, Chelsea and Westminster Hospital, London
Against the motion:
Dr Sanjay Bhagani, Royal Free Hospital, London
BHIVA is grateful for an educational grant in support of this debate from Boehringer Ingelheim Ltd.
BHIVA Keynote Lecture
HIV medicine and the new NHS
Ms Candace Imison, The King's Fund
Oral Research Presentations: Session 4 - Antiretroviral treatment
Abstract O25 - Elvitegravir /cobicistat /emtricitabine/tenofovir DF (Quad) has non-inferior efficacy and favorable safety compared to efavirenz /emtricitabine/tenofovir DF in treatment naïve HIV-1 infected subjects
Dr Anthony Mills, Anthony Mills MD Inc, Los Angeles, USA
Abstract O26 - Efficacy, safety and pharmacokinetic results of an ongoing international phase 3 study comparing elvitegravir /cobicistat /emtricitabine/tenofovir DF (Quad) with ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF in treatment naïve HIV-1 infected subjects at 48 weeks
Dr Chloe Orkin, Barts and The London NHS Trust
Abstract O27 - Intensification of suppressive ART with maraviroc reduces CD4 T-cell activation, increases early stage CD8 T cells and improves anti-HIV-1 function, without detriment to humoral recall response
Dr Samantha Westrop, Imperial College, London
Abstract O28 - An investigation into the frequency and reasons why patients switch antiretroviral therapy and which antiretrovirals are commonly implicated in toxicity
Ms Alison Boyle, Chelsea and Westminster Hospital, London
Abstract O29 - Effects of HIV/HCV co-infection on the efficacy of antiretroviral treatment for HIV: a meta-analysis of 5408 patients in 10 randomised clinical trials
Dr Andrew Hill, University of Liverpool
Abstract O30 - The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort
Dr Naomi Bulteel, Chelsea and Westminster Hospital, London
Oral Research Poster Presentations
P6 Lost for good? - an audit of local guidelines to return HIV patients back to care
Dr Jessica Doctor, St Marys Hospital, London
P27 Prescribing of non-HIV related medications – a move back to primary care
Dr Cara Mullooly, University Hospitals of South Manchester NHS Foundation Trust
P64 Treatment of anal intraepithelial neoplasia and prevention of anal carcinoma
Dr John Thornhill, Homerton University Hospital
P73 The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland
Dr Shema Tariq, City University, London
P128 A novel replacement and maintenance regimen for vitamin D de?cient HIV positive patients
Ms Jordana Freemantle and Dr Sophia Davies, Birmingham Heartlands Hospital
P225 Process and psychological ?ndings of implementing a behavioural change program for adherence in young people with perinatally acquired HIV infection (PaHIV) using ?nancial incentives and Motivational Interviewing
Miss Susan McDonald, Imperial College Healthcare NHS Trust, London
BHIVA Lunchtime Workshop 5
Managing ongoing high-risk behaviour in MSM
Dr John Green, Central and North West London NHS Foundation Trust
BHIVA Lunchtime Workshop 6 - Difficult pharmacology case presentations
A direct hit
Dr Andy Williams, Barts and The London NHS Trust
36 points
Dr Nadia Gupta, Royal Hallamshire Hospital, Sheffield
Making mountains out of molehills
Mr Neal Marshall, Royal Free Hospital, London
BHIVA Invited Lecture 3
The role of the HIV physician in HIV/ hepatitis co-infection
Dr Ranjababu Kulasegaram, St Thomas' Hospital, London
BHIVA Plenary Session 4 - ART now, ART to come
Spoilt for choice? Switching antiretrovirals
Professor Georg Behrens, Hannover Medical School, Germany
New targets for HIV replication
Professor Mario Stevenson, University of Miami Leonard M Miller School of Medicine, Florida, USA
